{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:57:35Z","timestamp":1787068655204,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Japanese Ministry of Health, Labour and Welfare"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>The aim of this retrospective cohort study was to assess the cumulative development incidence and predictive factors for malignancies after the termination of interferon (IFN) therapy in Japanese patients for hepatitis C virus (HCV). A total of 4,302 HCV-positive patients treated with IFN were enrolled. The mean observation period was 8.1 years. The primary outcome was the first onset of malignancies. Evaluation was performed using the Kaplan-Meier method and Cox proportional hazard analysis. A total of 606 patients developed malignancies: 393 developed hepatocellular carcinoma (HCC) and 213 developed malignancies other than HCC. The cumulative development rate of HCC was 4.3% at 5 years, 10.5% at 10 years, and 19.7% at 15 years. HCC occurred significantly<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.05) when the following characteristics were present: advanced histological staging, sustained virological response not achieved, male sex, advanced age of \u226550 years, total alcohol intake of \u2265200 kg, and presence of type 2 diabetes (T2DM). T2DM caused a 1.73-fold enhancement in HCC development. In patients with T2DM, HCC decreased when patients had a mean hemoglobin A1c (HbA1c) level of &lt;7.0% during follow-up (hazard ratio, 0.56; 95% confidence interval, 0.33\u20130.89;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.015). The cumulative development rate of malignancy other than HCC was 2.4% at 5 years, 5.1% at 10 years, and 9.8% at 15 years. Malignancies other than HCC occurred significantly when patients were of advanced age of \u226450 years, smoking index (package per day \u00d7 year) was \u2265 20, and T2DM was present. T2DM caused a 1.70-fold enhancement in the development of malignancies other than HCC.<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>T2DM causes an approximately 1.7-fold enhancement in the development of HCC and malignancies other than HCC in HCV-positive patients treated with IFN. In T2DM patients, maintaining a mean HbA1c level of &lt;7.0% reduces the development of HCC. (Hepatology 2013)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.26087","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T07:18:26Z","timestamp":1347952706000},"page":"964-973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":160,"title":["Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C"],"prefix":"10.1097","volume":"57","author":[{"given":"Yasuji","family":"Arase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20241201","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1440-1746.1991.tb00876.x","article-title":"Review of hepatitis C in Japan.","volume":"6","author":"Kiyosawa","year":"1991","journal-title":"J Gastroenterol Hepatol"},{"key":"RU2-17-20241201","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community acquired hepatitis C in the United States.","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"R3-17-20241201","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(89)91016-7","article-title":"Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.","volume":"2","author":"Colombo","year":"1989","journal-title":"Lancet"},{"key":"R4-17-20241201","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.1840120323","article-title":"Hepatitis Cassociated hepatocellular carcinoma.","volume":"12","author":"Hasan","year":"1990","journal-title":"HEPATOLOGY"},{"key":"R5-17-20241201","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(90)90474-J","article-title":"Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.","volume":"335","author":"Kew","year":"1990","journal-title":"Lancet"},{"key":"R6-17-20241201","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease.","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"R7-17-20241201","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.1840180109","article-title":"A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.","volume":"18","author":"Ikeda","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R9-17-20241201","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00042737-200608000-00006","article-title":"Early gastric cancer: diagnosis, treatment techniques and outcomes.","volume":"18","author":"Yasuda","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R10-17-20241201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1179\/acb.2010.65.6.012","article-title":"Guidelines for colorectal cancer screeninga puzzle of tests and strategies.","volume":"65","author":"Van Gossum","year":"2010","journal-title":"Acta Clin Belg"},{"key":"R11-17-20241201","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/qjmed\/hcp038","article-title":"Tools used in the diagnosis and staging of lung cancer: whats old and whats new?","volume":"102","author":"Currie","year":"2009","journal-title":"QJM"},{"key":"R12-17-20241201","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/1471-2407-10-680","article-title":"Differential expression of anterior gradient gene AGR2 in prostate cancer.","volume":"10","author":"Maresh","year":"2010","journal-title":"BMC Cancer"},{"key":"R13-17-20241201","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Eng J Med"},{"key":"R14-17-20241201","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised EuropeanAmerican classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"R17-17-20241201","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.1840190104","article-title":"Hepatitis C virus genotypes: an investigation of typespecific differences in geographic origin and disease.","volume":"19","author":"Dusheiko","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R18-17-20241201","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging.","volume":"19","author":"Desmet","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R19-17-20241201","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0197-2456(84)80014-8","article-title":"Designs for group sequential tests.","volume":"5","author":"Fleming","year":"1984","journal-title":"Control Clin Trials"},{"key":"R20-17-20241201","first-page":"205","article-title":"A class of rank test procedures for censored survival data.","volume":"62","author":"Harrington","year":"1983","journal-title":"Biomedaica"},{"key":"RU21-17-20241201","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation for incomplete observation.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R22-17-20241201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"RU23-17-20241201","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.510290439","article-title":"Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C; A longterm observation study of 1643 patients using statistical bias correction with proportional hazard analysis.","volume":"29","author":"Ikeda","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R27-17-20241201","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","article-title":"Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.","volume":"47","author":"Veldt","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R28-17-20241201","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23691","article-title":"Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.","volume":"52","author":"Asahina","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R29-17-20241201","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyq169","article-title":"The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 populationbased cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.","volume":"41","author":"Matsuda","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"R30-17-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(97)00648-X","article-title":"Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.","volume":"17","author":"Boyle","year":"1997","journal-title":"Lung Cancer"},{"key":"RU31-17-20241201","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.2008.839","article-title":"Smoking and colorectal cancer: a metaanalysis.","volume":"300","author":"Botteri","year":"2008","journal-title":"JAMA"},{"key":"R32-17-20241201","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer. A metaanalysis.","volume":"273","author":"Everhart","year":"1995","journal-title":"JAMA"},{"key":"R33-17-20241201","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.","volume":"4","author":"ElSerag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-17-20241201","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","article-title":"Diabetes mellitus and risk of bladder cancer: a metaanalysis.","volume":"49","author":"Larsson","year":"2006","journal-title":"Diabetologia"},{"key":"R35-17-20241201","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2337\/dc08-1034","article-title":"Diabetes and risk of nonHodgkins lymphoma: a metaanalysis of observational studies.","volume":"31","author":"Mitri","year":"2008","journal-title":"Diabetes Care"},{"key":"R36-17-20241201","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a metaanalysis.","volume":"97","author":"Larsson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R37-17-20241201","doi-asserted-by":"crossref","first-page":"836S","DOI":"10.1093\/ajcn\/86.3.836S","article-title":"Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.","volume":"86","author":"Giovannucci","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R38-17-20241201","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a metaanalysis.","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"R39-17-20241201","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jnci\/95.1.67","article-title":"Insulin resistance and prostate cancer risk.","volume":"95","author":"Hsing","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R40-17-20241201","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The reninangiotensin system and cancer: old dog, new tricks.","volume":"10","author":"George","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R41-17-20241201","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1AMPK pathway: metabolism and growth control in tumour suppression.","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R42-17-20241201","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor.","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"R43-17-20241201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes.","volume":"38","author":"Mehta","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R44-17-20241201","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1478-3231.2007.01630.x","article-title":"Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virusinfected and hepatitis C viruscleared patients.","volume":"28","author":"Imazeki","year":"2008","journal-title":"Liver Int"},{"key":"R45-17-20241201","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.","volume":"49","author":"Arase","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R46-17-20241201","first-page":"438","article-title":"Association between hepatitis C, diabetes mellitus, and race. a casecontrol study.","volume":"98","author":"Thuluvath","year":"2003","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26087","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26087","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201303000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:07:14Z","timestamp":1733044034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201303000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26087","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}